Colorado's bioscience industry is building one of the most exciting and advanced industry clusters in the country. The state is currently home to a thriving industry, comprised of biotechnology, medical device, agricultural-bioscience, diagnostic, pharmaceutical, health care providers, research institutions and those businesses that provide critical services and products to bioscience companies.
The bioscience industry in Colorado is a vital part of the state’s economy, with employment growth surpassing the national average. Over 90 percent of the companies are located along the Front Range in close proximity to Colorado’s nationally ranked research institutions.
Over the last five years, many infrastructure investments have been made in the industry including the development of the $5.3 billion Fitzsimons Life Science District and the BIO Frontiers Institute, a 300,000 sq. ft., $300 million multi-disciplinary research center. Funding in bioscience is critical, and Colorado has developed several programs to help bioscience companies thrive. Recent legislation renewed a $25 million grant program for technologies licensed out of Colorado research institutions, as well as an additional stream of funding that requires 25 percent of the net increase in future corporate income tax withholdings from bioscience businesses to support proof of concept, early stage companies and infrastructure assistance programs.